Liquidia Corporation to Present at 2026 Jefferies Global Healthcare Conference
Globe Newswire•10/11/2026•08:00 ET
0
Key Highlights
- ➤Liquidia (LQDA) executives to present a business update at Jefferies conference
- ➤Fireside chat scheduled for November 17 at 10 a.m. ET
- ➤YUTREPIA approved for pulmonary arterial hypertension treatment
- ➤L606 in development for PAH and PH-ILD
MORRISVILLE, N.C., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Dr. Roger Jeffs, Chief Executive Officer, and Michael Kaseta, Chief Operating Officer and Chief Financial Officer, will provide an update on the company’s business in a fireside chat at the 2026 Jefferies Global Healthcare Conference, Tuesday, November 17, at 10 a.m. ET/3 p.m. BT in London.
Access to these events will be available on the “Investors” page of Liquidia’s website at https://liquidia.com/investors/events-and-presentations. A replay of the webcast will be archived on the Company's website for at least 30 days.
Get started
Create a free account to read the full story.